Biotech stocks came under selling pressure as early as the day before yesterday (7th), before northbound funds resumed trading, when the biotech index dropped 2.7%. Then, after northbound trading resumed yesterday, selling pressure intensified further, with the biotech index plunging over 600 points for the day, down 3.8%. Today, the biotech sector continues its downward trend from the previous two days. Currently, the biotech index has fallen over 2.2%, standing at 15,336 points, down 348 points. The biotech index has accumulated a three-day decline of 8.7%. At present, the healthcare sector records an active net outflow of approximately HK$280 million, making it the sector with the largest capital outflow.
Currently, the Hang Seng Index stands at 24,070, up 284 points or 1.2%. Main board turnover exceeds HK$37.2 billion. The Hang Seng China Enterprises Index stands at 8,103, up 92 points or 1.2%. The Hang Seng Tech Index stands at 4,158, up 85 points or 2.1%.
| Stock (Code) | Current Price (HK$) | Change (%) |
|---|---|---|
| WuXi Biologics (02269) | 52.05 | Down 3.79% |
| WuXi XDC (02268) | 78.65 | Down 4.38% |
| XTALPi (02228) | 6.88 | Down 3.64% |
| BeiGene (06160) | 206.8 | Down 2.91% |
| Abogen Biosciences (09926) | 103.2 | Down 2.37% |
| CSPC Pharmaceutical Group (01093) | 9.015 | Down 2.91% |
| Colun Biotech (06990) | 434.6 | Down 2.51% |
| Innovent Biologics (01801) | 91 | Down 1.73% |
| China Biologic Products (01177) | 5.41 | Down 1.37% |
| Hansoh Pharmaceutical (03692) | 31.54 | Down 1.99% |